CVE-2022-0155

Public Exploit
Exposure of Private Personal Information to an Unauthorized Actor in follow-redirects/follow-redirects

Description

follow-redirects is vulnerable to Exposure of Private Personal Information to an Unauthorized Actor

Category

6.5
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.93% Top 30%
Third-Party Advisory siemens.com Third-Party Advisory github.com Third-Party Advisory huntr.dev
Affected: follow-redirects follow-redirects/follow-redirects
Published at:
Updated at:

References

Link Tags
https://huntr.dev/bounties/fc524e4b-ebb6-427d-ab67-a64181020406 patch third party advisory exploit
https://github.com/follow-redirects/follow-redirects/commit/8b347cbcef7c7b72a6e9be20f5710c17d6163c22 third party advisory patch
https://cert-portal.siemens.com/productcert/pdf/ssa-637483.pdf third party advisory patch

Frequently Asked Questions

What is the severity of CVE-2022-0155?
CVE-2022-0155 has been scored as a medium severity vulnerability.
How to fix CVE-2022-0155?
To fix CVE-2022-0155, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-0155 being actively exploited in the wild?
It is possible that CVE-2022-0155 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-0155?
CVE-2022-0155 affects follow-redirects follow-redirects/follow-redirects.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.